Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shanghai Runda Medical Technology Co (SHSE:603108) Cash Conversion Cycle Explanation
Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.
Be Aware
CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.
The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.
Shanghai Runda Medical Technology Co Cash Conversion Cycle Related Terms
Shanghai Runda Medical Technology Co Cash Conversion Cycle Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Runda Medical Technology Co Cash Conversion Cycle Chart
SHSE:603108 vs TMO, DHR, IDXX: Cash Conversion Cycle Comparison
For the Diagnostics & Research subindustry, Shanghai Runda Medical Technology Co's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Runda Medical Technology Co Cash Conversion Cycle vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Shanghai Runda Medical Technology Co's Cash Conversion Cycle distribution charts can be found below:
* The bar in red indicates where Shanghai Runda Medical Technology Co's Cash Conversion Cycle falls into.
Shanghai Runda Medical Technology Co Cash Conversion Cycle Calculation
Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.
Cash Conversion Cycle is one of several measures of management effectiveness.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Runda Medical Technology Co (SHSE:603108) has a Cash Conversion Cycle of 310.21 as of Mar. 2026. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Shanghai Runda Medical Technology Co and its competitors.
Is Shanghai Runda Medical Technology Co's Cash Conversion Cycle too high?
Shanghai Runda Medical Technology Co's current Cash Conversion Cycle is 310.21. The Medical Diagnostics & Research industry median Cash Conversion Cycle is 72.23. Shanghai Runda Medical Technology Co's value of 310.21 is 329.5% above this industry median. Overall, Shanghai Runda Medical Technology Co has a GF Score™ of 39/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Shanghai Runda Medical Technology Co's Cash Conversion Cycle compare to TMO and DHR?
Shanghai Runda Medical Technology Co's Cash Conversion Cycle of 310.21 can be compared against companies in the Medical Diagnostics & Research industry. The industry median Cash Conversion Cycle is 72.23. Shanghai Runda Medical Technology Co's value of 310.21 is 329.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Conversion Cycle for a Medical Diagnostics & Research company?
The median Cash Conversion Cycle among Medical Diagnostics & Research companies is 72.23, based on 203 companies in the industry. Companies in the top quartile (top 25%) have a Cash Conversion Cycle significantly above this median, while those in the bottom quartile fall well below. However, Cash Conversion Cycle should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Runda Medical Technology Co's current Cash Conversion Cycle of 310.21 is 329.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Conversion Cycle mean?
A high Cash Conversion Cycle can signal that a stock is expensive relative to its fundamentals. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Shanghai Runda Medical Technology Co and its competitors. For the Medical Diagnostics & Research industry, the median Cash Conversion Cycle is 72.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Runda Medical Technology Co's current Cash Conversion Cycle is 310.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Runda Medical Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Runda Medical Technology Co (SHSE:603108) is currently considered Possible Value Trap. The stock's GF Value™ is ¥17.89, compared to a current price of ¥10.01 — trading 44% below its estimated fair value. The current Cash Conversion Cycle is 310.21 and 329.5% above the Medical Diagnostics & Research industry median of 72.23. Shanghai Runda Medical Technology Co's overall GF Score™ is 39/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Conversion Cycle calculated?
Cash Conversion Cycle is calculated from a company's financial statements. For Shanghai Runda Medical Technology Co (SHSE:603108), the current Cash Conversion Cycle is 310.21 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Runda Medical Technology Co (SHSE:603108) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Runda Medical Technology Co stock appears to be undervalued.
The current stock price of ¥10.01 is trading 44% below its estimated GF Value™ of ¥17.89.
GuruFocus considers Shanghai Runda Medical Technology Co to be Possible Value Trap.
Key valuation signals for SHSE:603108:
Cash Conversion Cycle: 310.21
GF Value™: ¥17.89 vs. price of ¥10.01 (44% below fair value)
Industry Position: 329.5% above the Medical Diagnostics & Research median
No single metric tells the full story. See the SHSE:603108 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai Runda Medical Technology Co Ltd is a medical laboratory integrated service provider based in East China. The company provides in-vitro diagnostic products and professional technical support to various medical laboratories.
39GF Score
Get the complete analysis for SHSE:603108
Cash Conversion Cycle is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603108 has been successfully added to your 
